2026 · 2nd Quarter (Apr 1 - June 30)

RARE DISEASE COMPANY COALITION

Filed by FEROX STRATEGIES.

Open official filing

Source-reported fields

Filing overview

Type: 2nd Quarter - Report
Posted: Jul 20, 2026
Income: $50,000.00
Expenses: Not reported
Registrant: FEROX STRATEGIES
Client: RARE DISEASE COMPANY COALITION
Filing UUID: 40e9558a-5310-4773-9b55-93812231b3c3
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

TRD · Trade (domestic/foreign)

General issues related to tariffs.

TAX · Taxation/Internal Revenue Code

General issues related to rare disease treatment development.

HCR · Health Issues

General issues related to rare disease treatment.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.